222 related articles for article (PubMed ID: 11330572)
1. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?
Duman S; Günal AI; Sen S; Asçi G; Ozkahya M; Terzioglu E; Akçiçek F; Atabay G
Perit Dial Int; 2001; 21(2):219-24. PubMed ID: 11330572
[TBL] [Abstract][Full Text] [Related]
2. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F
Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386
[TBL] [Abstract][Full Text] [Related]
3. Effect of valsartan versus lisinopril on peritoneal sclerosis in rats.
Duman S; Sen S; Duman C; Oreopoulos DG
Int J Artif Organs; 2005 Feb; 28(2):156-63. PubMed ID: 15770604
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in rats.
Duman S; Sen S; Sozmen EY; Oreopoulos DG
Int J Artif Organs; 2005 Feb; 28(2):170-6. PubMed ID: 15770605
[TBL] [Abstract][Full Text] [Related]
5. The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.
Bozkurt D; Cetin P; Sipahi S; Hur E; Nar H; Ertilav M; Sezak M; Duman S
Perit Dial Int; 2008 Nov; 28 Suppl 5():S38-42. PubMed ID: 19008539
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum.
Duman S; Wieczorowska-Tobis K; Styszynski A; Kwiatkowska B; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2004; 20():31-6. PubMed ID: 15384791
[TBL] [Abstract][Full Text] [Related]
7. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
8. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution.
Günal AI; Duman S; Sen S; Unsal A; Terzioğlu E; Akçiçek F; Basci A
J Nephrol; 2001; 14(3):184-9. PubMed ID: 11439742
[TBL] [Abstract][Full Text] [Related]
9. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
10. Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?
Bozkurt D; Hur E; Ulkuden B; Sezak M; Nar H; Purclutepe O; Sen S; Duman S
Perit Dial Int; 2009 Feb; 29 Suppl 2():S202-5. PubMed ID: 19270218
[TBL] [Abstract][Full Text] [Related]
11. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal infusion of glucose-based dialysate in the rat--an animal model for the study of peritoneal advanced glycation end-products formation and effect on peritoneal transport.
Zeltzer E; Klein O; Rashid G; Katz D; Korzets Z; Bernheim J
Perit Dial Int; 2000; 20(6):656-61. PubMed ID: 11216555
[TBL] [Abstract][Full Text] [Related]
13. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
14. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
[TBL] [Abstract][Full Text] [Related]
15. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
[TBL] [Abstract][Full Text] [Related]
17. Overnight mesothelial cell exfoliation: a magic tool for predicting future ultrafiltration failure in patients on continuous ambulatory peritoneal dialysis.
Kanjanabuch T; Siribamrungwong M; Khunprakant R; Kanjanabuch S; Jeungsmarn P; Achavanuntakul B; Pongpirul K; Park MS; Tungsanga K; Eiam-Ong S
Perit Dial Int; 2008 Jun; 28 Suppl 3():S107-13. PubMed ID: 18552238
[TBL] [Abstract][Full Text] [Related]
18. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
20. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E
Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
